![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_1d5eba4b4bb57896dda18b1604bab021.svg) | Staurosporine | IC50 | 200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_7961b7d34200173094dbc303cf301e2d.svg) | Bms-536924 | IC50 | 100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_404efa449e924ed4ca6b994805bc6261.svg) | Linsitinib | IC50 | 13.0 [1] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_24fd6d23fa2ef41b800d979f2fda4ef4.svg) | N-[4-[[5,5-Dimethyl-2,4-dioxo-3-[4-(trifluoromethylsulfanyl)phenyl]imidazolidin-1-yl]methyl]pyridin-2-yl]acetamide | IC50 | 28.0 [1] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_5c01e5f6d4af8bc5d81a6290369fc247.svg) | 1-(5-Chloro-2-methoxyphenyl)-3-(2-methylquinolin-4-yl)urea | IC50 | 12000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_be3309e3df14b1fdfb5483be50694fb6.svg) | 2-(5,6-Dimethoxy-1-methyl-1h-indol-3-yl)-1h-pyrrolo[2,3-b]pyridine | IC50 | 35.0 [1] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_4fb0b339e55a9a82aa646306f39d820c.svg) | 2-Fluoro-6-[[2-[2-methoxy-4-(4-propan-2-ylpiperazin-1-yl)anilino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]benzamide | IC50 | 2.0 [1] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_8eae72d177a0cb4ada7fcb23f512c695.svg) | N-[(3-{4-Amino-5-[3-(Benzyloxy)phenyl]-7h-Pyrrolo[2,3-D]pyrimidin-7-Yl}cyclobutyl)methyl]acetamide | IC50 | 50.0 [1] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_a257c791d1de1df5d4a1fa04612f9c76.svg) | Nvp-aew541 | IC50 | 20.0 [1], 60.0 [2], 61.0 [3], 65.0 [4] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_f02c1e14dc540300fe73303dae37c549.svg) | N-(2,6-Difluorophenyl)-5-[3-[2-[5-ethyl-2-methoxy-4-[4-(4-methylsulfonylpiperazin-1-yl)piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-2-methoxybenzamide | IC50 | 22.0 [1], 27.0 [2], 100.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_f02c1e14dc540300fe73303dae37c549.svg) | N-(2,6-Difluorophenyl)-5-[3-[2-[5-ethyl-2-methoxy-4-[4-(4-methylsulfonylpiperazin-1-yl)piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-2-methoxybenzamide | Ki | 1.6 [1] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_fbee178cbabedfff4c99ea314d739aab.svg) | 2-[[2-[[1-[2-(Dimethylamino)acetyl]-5-methoxy-2,3-dihydroindol-6-yl]amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]-6-fluorobenzamide | IC50 | 1.0 [1], 54.0 [2], 56.0 [3], 487.0 [4] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_09f75848c2cf6e9b11469658f1d9a7db.svg) | 4-[[1,3-Benzodioxol-5-yl-[(3,4-dihydroxyphenyl)methyl]amino]methyl]benzene-1,2-diol | IC50 | 170.0 [1], 3900.0 [2], 5300.0 [3], 6200.0 [4] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_61e35f14f954be8e3682806c9c1e007d.svg) | N-[4-[4-Amino-1-[4-(4-methylpiperazin-1-yl)cyclohexyl]pyrazolo[3,4-d]pyrimidin-3-yl]phenyl]-7-chloro-1,3-benzoxazol-2-amine | IC50 | 12.5 [1], 77.0 [2], 207.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_836d745853fbc6ec97f11eacace589b6.svg) | N-(2,6-Difluorophenyl)-3-[3-[2-[2-methoxy-4-[4-(4-methylsulfonylpiperazin-1-yl)piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide | IC50 | 5.0 [1], 36.0 [2], 100.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_836d745853fbc6ec97f11eacace589b6.svg) | N-(2,6-Difluorophenyl)-3-[3-[2-[2-methoxy-4-[4-(4-methylsulfonylpiperazin-1-yl)piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide | Ki | 5.2 [1] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_85ff224d947e5d3dd8571dad2bde13d9.svg) | N-[4-[4-Amino-1-[4-(4-methylpiperazin-1-yl)cyclohexyl]pyrazolo[3,4-d]pyrimidin-3-yl]-2-fluorophenyl]-7-chloro-1,3-benzoxazol-2-amine | IC50 | 7.5 [1], 72.0 [2], 87.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_7d931db63c9b858090d8da11ccc71d4c.svg) | Bms-754807 | IC50 | 2.0 [1], 2.1 [2], 8.4 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_0d9d66d2888c44b4d24fe952f41b1ba6.svg) | CID 9825149 | IC50 | 50.0 [1], 78.0 [2], 323.0 [3], 500.0 [4] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_a608c84b2f4e60f4f2981dfa52493005.svg) | 3-Cyclobutyl-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-8-amine | IC50 | 79.0 [1], 80.0 [2], 86.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_26da448953560fd808f3343ada3da63d.svg) | 4-[[2-(3-Chlorophenyl)-2-hydroxyethyl]amino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one | IC50 | 180.0 [1], 370.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_5cf40b2f6460df5e6308485eaa394cd0.svg) | 3-[cis-3-(4-Methylpiperazin-1-yl)cyclobutyl]-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-8-amine | IC50 | 19.0 [1], 37.0 [2], 58.0 [3], 65.0 [4] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_b43f9b172387f2a84cebdafc2497da4c.svg) | cis-3-[4-Amino-7-(3-azetidin-1-ylmethyl-cyclobutyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]-phenol | IC50 | 420.0 [1], 454.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_101f274fa0d894c601461fd7747171a3.svg) | 7-[3-(Azetidin-1-ylmethyl)cyclobutyl]-5-[3-[[(2S)-oxolan-2-yl]methoxy]phenyl]pyrrolo[2,3-d]pyrimidin-4-amine | IC50 | 12.0 [1], 80.0 [2], 84.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_78777219c74410e202b7a451a4d28ce1.svg) | cis-3-(3-Pyrrolidin-1-ylmethylcyclobutyl)-1-(3-benzyloxyphenyl)-imidazo[1,5-a]pyrazin-8-ylamine | IC50 | 89.0 [1], 116.0 [2], 401.0 [3], 621.0 [4] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_d78a534307769f62cd31baab1dea8d58.svg) | cis-3-(3-Azetidin-1-ylmethylcyclobutyl)-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-8-ylamine | IC50 | 20.0 [1], 35.0 [2], 42.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_aeb2cf068cb71c8863ce2c76c99ea9ee.svg) | 2-Fluoro-6-[[2-[2-methoxy-5-(4-propan-2-ylpiperazin-1-yl)anilino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]benzamide | IC50 | 4.0 [1], 160.0 [2], 201.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_2a01f3e1d18748ca35fc9909601a9476.svg) | 2-Fluoro-6-[[2-[2-methoxy-4-methyl-5-(4-propan-2-ylpiperazin-1-yl)anilino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]benzamide | IC50 | 20.0 [1], 270.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_e21b9488066b963e6c201b7947ab10fe.svg) | 1-[4-[4-[(5-Chloro-4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]-3-methoxyphenyl]piperazin-1-yl]ethanone | IC50 | 9.0 [1], 10.0 [2], 17.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_84ed7c181f856d27a986dd854c28548f.svg) | trans-3-(8-Amino-1-(3-(benzyloxy)phenyl)imidazo[1,5-a]pyrazin-3-yl)cyclobutanecarboxamide | IC50 | 526.0 [1], 554.0 [2], 1710.0 [3], 2080.0 [4] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_4096ca3ad896e6c657ec3573305eef53.svg) | trans-4-(8-Amino-1-(3-(benzyloxy)phenyl)imidazo[1,5-a]pyrazin-3-yl)cyclohexanecarboxamide | IC50 | 221.0 [1], 775.0 [2], 898.0 [3], 8570.0 [4] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_10a365feb01d554082f433b45e49bf2d.svg) | cis-3-(4-(Aminomethyl)cyclohexyl)-1-(3-(benzyloxy)phenyl)imidazo[1,5-a]pyrazin-8-amine | IC50 | 119.0 [1], 228.0 [2], 534.0 [3], 560.0 [4] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_8e9a4d34cf5ea58f3a8ae3e63448db91.svg) | N-(2,6-Difluorophenyl)-3-[3-[2-[2-methoxy-4-(4-piperidin-1-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide | IC50 | 2.0 [1], 38.0 [2], 100.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_14e575b7a1f05beddeef685dba090ffb.svg) | N-(2,6-Difluorophenyl)-3-[3-[2-[3-[2-(dimethylamino)ethoxy]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide | IC50 | 1.0 [1], 100.0 [2], 177.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_b886465bf262cc1c62d11569a06a565e.svg) | N-(2,6-Difluorophenyl)-3-[3-[2-[4-(4-piperidin-1-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide | IC50 | 2.0 [1], 87.0 [2], 100.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_4c55ca403aaf9bc6cbbf3c7d4ff74204.svg) | N-(2,6-Difluorophenyl)-3-[3-[2-[2-methoxy-4-(4-morpholin-4-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide | IC50 | 2.0 [1], 41.0 [2], 100.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_f773965f86f390273c276aef263046f9.svg) | N-(2,6-Difluorophenyl)-3-[3-[2-[2-methoxy-4-(4-pyrrolidin-1-ylpiperidin-1-yl)anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide | IC50 | 2.0 [1], 38.0 [2], 100.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_d2c588383c38ba1635d27514bac8d456.svg) | N-(2,6-Difluorophenyl)-3-[3-[2-[4-[4-[(3R)-3-fluoropyrrolidin-1-yl]piperidin-1-yl]-2-methoxyanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide | IC50 | 2.0 [1], 40.0 [2], 100.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_a2acbe1160a3239362b6ee9c72890643.svg) | N-(2,6-Difluorophenyl)-3-[3-[2-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide | IC50 | 2.0 [1], 28.0 [2], 100.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_72915ef58d6b5b6f65edaa1354ee71f4.svg) | N-(2,6-Difluorophenyl)-3-[3-[2-[4-[4-[(2R,6S)-2,6-dimethylmorpholin-4-yl]piperidin-1-yl]-2-methoxyanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide | IC50 | 4.0 [1], 68.0 [2], 100.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_bbe9eb048b07dc1ea8ec72598d2c6292.svg) | 3-[3-[2-[4-[4-(4-Acetylpiperazin-1-yl)piperidin-1-yl]-2-methoxyanilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-N-(2,6-difluorophenyl)benzamide | IC50 | 3.0 [1], 65.0 [2], 100.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_222ce15885e1c8722bc7e8a2790707ee.svg) | N-[4-[4-Amino-1-[4-(4-propan-2-ylpiperazin-1-yl)cyclohexyl]pyrazolo[3,4-d]pyrimidin-3-yl]phenyl]-7-chloro-1,3-benzoxazol-2-amine | IC50 | 45.1 [1], 174.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_4f0a5dc1cd86766976083dae0b0db7a8.svg) | N-[4-[4-Amino-1-[4-[4-(3-methoxypropyl)piperazin-1-yl]cyclohexyl]pyrazolo[3,4-d]pyrimidin-3-yl]phenyl]-7-chloro-1,3-benzoxazol-2-amine | IC50 | 72.4 [1], 424.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_4c1c8e479c2e24660577929dfcea7599.svg) | 1-[4-[3-[4-Amino-5-[2-fluoro-5-[[(2S)-oxolan-2-yl]methoxy]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclobutyl]piperazin-1-yl]ethanone | IC50 | 12.0 [1], 13.0 [2], 16.0 [3], 54.0 [4] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_2ddb86a845dd53e22d857def167eb764.svg) | 3-[8-Amino-1-(4-methoxy-2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutan-1-ol | IC50 | 0.7 [1], 3.0 [2], 7.1 [3], 320.0 [4] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_5888a69faa06d7673b60451157c16f76.svg) | 4-[2-[3-(2-Aminoethyl)-1-[[4-[3-(trifluoromethyl)phenyl]phenyl]methyl]indol-5-yl]oxyethyl]phenol | IC50 | 1020.0 [1], 1060.0 [2], 1070.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_cd9f15e0c61bee3cf9b0be466db547a0.svg) | 4-[2-[[6-Amino-9-(5-phenylpentyl)-5,6,7,8-tetrahydrocarbazol-3-yl]oxy]ethyl]phenol | IC50 | 930.0 [1], 990.0 [2], 1220.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_f855e9b35482adcfcf3b5936b0a1b113.svg) | N-(2,6-Difluorophenyl)-3-[3-[2-[2-methoxy-4-[4-[4-(2-methylsulfonylethyl)piperazin-1-yl]cyclohexyl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide | IC50 | 100.0 [1] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_18f55b548b3a1ed14c0f1de84167a9fd.svg) | N-[[3-[4-Amino-5-[3-[(2-chlorophenyl)methoxy]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclobutyl]methyl]acetamide | IC50 | 50.0 [1], 500.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_4105c978ce6591580913a1d5de4cb25e.svg) | N-[[3-[4-Amino-5-(3-hydroxyphenyl)pyrrolo[2,3-d]pyrimidin-7-yl]cyclobutyl]methyl]acetamide | IC50 | 50.0 [1], 5000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_c77eb69f87d46b4d00314a6bfb851cf8.svg) | Crizotinib | IC50 | 143.0 [1], 1000.0 [2], 10000.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_2adbc4a307d22bed17e0f710542542e9.svg) | Entrectinib | IC50 | 122.0 [1], 263.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_0083846044398ddf7c45cff272939f8a.svg) | CID 25182616 | IC50 | 2.0 [1], 85.0 [2], 310.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_ac9e30b723e2c9bf1debc2a45966acbb.svg) | 3-(1H-Indol-3-yl)-4-(3,4,5-trimethoxyphenyl)pyrrole-2,5-dione | IC50 | 6967.0 [1], 9900.0 [2], 13000.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_d986d160743672902d958e8ae7748011.svg) | 5-Fluoro-2-[[2-[2-methoxy-4-(4-propan-2-ylpiperazin-1-yl)anilino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]benzamide | IC50 | 0.8 [1], 0.9 [2], 60.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_98379f3b7b4f320e98ceb3d8c084218f.svg) | 3-(5-(1H-Imidazol-1-yl)-7-methyl-1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one | IC50 | 3500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_e754a8c6e595c5716dbdb01476ca95a3.svg) | 1-(3-Benzyloxy-phenyl)-3-cyclobutyl-imidazo[1,5-a]pyrazin-8-ylamine | IC50 | 606.0 [1], 1160.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_11248b699d5300db48bd572fcb035ba4.svg) | 4-[2-(4-Chloropyrazol-1-yl)ethylamino]-3-(4-methyl-6-morpholin-4-yl-1H-benzimidazol-2-yl)-1H-pyridin-2-one | IC50 | 120.0 [1], 376.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_a63b28e3ab5f3b69dd20c9fd12de40f2.svg) | 4-[2-(5-Chloro-1-methylimidazol-4-yl)ethylamino]-3-(4-methyl-6-morpholin-4-yl-1H-benzimidazol-2-yl)-1H-pyridin-2-one | IC50 | 38.0 [1], 336.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_274d13013deb7d10fc5d133d9f77378c.svg) | 4-[2-(5-Chloro-1-ethylimidazol-4-yl)ethylamino]-3-(4-methyl-6-morpholin-4-yl-1H-benzimidazol-2-yl)-1H-pyridin-2-one | IC50 | 83.0 [1], 469.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_fe0855f7a4549c3941bec290ed05c730.svg) | 4-[2-(5-Bromo-1-methylimidazol-4-yl)ethylamino]-3-(4-methyl-6-morpholin-4-yl-1H-benzimidazol-2-yl)-1H-pyridin-2-one | IC50 | 75.0 [1], 343.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_318473fcfc0c41e1b46ac7d49a986f0a.svg) | 4-[2-(1-Methylimidazol-4-yl)ethylamino]-3-(4-methyl-6-morpholin-4-yl-1H-benzimidazol-2-yl)-1H-pyridin-2-one | IC50 | 190.0 [1], 521.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_238a8196bfbcceb59e4c9292d1600eee.svg) | 4-[2-(1-Ethylimidazol-4-yl)ethylamino]-3-(4-methyl-6-morpholin-4-yl-1H-benzimidazol-2-yl)-1H-pyridin-2-one | IC50 | 480.0 [1], 583.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_7be9965d640bb188c68303c0d7321ae4.svg) | 4-[2-[1-(2-Methoxyethyl)imidazol-4-yl]ethylamino]-3-(4-methyl-6-morpholin-4-yl-1H-benzimidazol-2-yl)-1H-pyridin-2-one | IC50 | 550.0 [1], 1510.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_ef6a1c9d1e73d43131912673845b40fe.svg) | 3-(4-Methyl-6-morpholin-4-yl-1H-benzimidazol-2-yl)-4-[2-(1-propan-2-ylimidazol-4-yl)ethylamino]-1H-pyridin-2-one | IC50 | 360.0 [1], 365.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_65681201845c26e49634d059fab2ec9d.svg) | 4-[2-[5-Chloro-1-(2-methoxyethyl)imidazol-4-yl]ethylamino]-3-(4-methyl-6-morpholin-4-yl-1H-benzimidazol-2-yl)-1H-pyridin-2-one | IC50 | 290.0 [1], 622.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_d9648bbd405f3612533650990af6dbbe.svg) | 4-[2-(5-Chloro-1-propan-2-ylimidazol-4-yl)ethylamino]-3-(4-methyl-6-morpholin-4-yl-1H-benzimidazol-2-yl)-1H-pyridin-2-one | IC50 | 360.0 [1], 1140.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_9017765b3308b921f1b2a9b363fb8d3b.svg) | 4-[2-(2,5-Dichloro-1-methylimidazol-4-yl)ethylamino]-3-(4-methyl-6-morpholin-4-yl-1H-benzimidazol-2-yl)-1H-pyridin-2-one | IC50 | 160.0 [1], 306.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_4f22a5ab846e0b52da993b01d730a106.svg) | 3-(4-Methyl-6-morpholin-4-yl-1H-benzimidazol-2-yl)-4-[2-(4-methylpyrazol-1-yl)ethylamino]-1H-pyridin-2-one | IC50 | 110.0 [1], 397.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_ee4c12044259d635bd32f7b659cb76a4.svg) | 1-[2-[[3-(4-Methyl-6-morpholin-4-yl-1H-benzimidazol-2-yl)-2-oxo-1H-pyridin-4-yl]amino]ethyl]pyrazole-4-carbonitrile | IC50 | 680.0 [1], 821.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_0fc9c77e6a03261d43e6814f5c96a611.svg) | Ethyl 1-[2-[[3-(4-methyl-6-morpholin-4-yl-1H-benzimidazol-2-yl)-2-oxo-1H-pyridin-4-yl]amino]ethyl]pyrazole-4-carboxylate | IC50 | 68.0 [1], 531.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_cacb74e938ebcc27137a7f54f0f9e5b9.svg) | Methyl 1-[2-[[3-(4-methyl-6-morpholin-4-yl-1H-benzimidazol-2-yl)-2-oxo-1H-pyridin-4-yl]amino]ethyl]pyrazole-4-carboxylate | IC50 | 91.0 [1], 711.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_01c9fa3dec46f90ce1b8b48b02cf38a3.svg) | 3-(4-Methyl-6-morpholin-4-yl-1H-benzimidazol-2-yl)-4-(2-pyrazol-1-ylethylamino)-1H-pyridin-2-one | IC50 | 330.0 [1], 613.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_232a627f2b049789332093dc72c38bf0.svg) | 3-[2-[(2-Chlorophenyl)methyl]-3H-benzimidazol-5-yl]-1-(4-morpholin-4-ylcyclohexyl)pyrazolo[3,4-d]pyrimidin-4-amine | IC50 | 36.0 [1], 37.0 [2], 90.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_5c4e0dd968ff4c7b824f02dc61dead52.svg) | 4-[3-Chloro-4-(1-ethyl-4,5-dimethylimidazol-2-yl)sulfanylanilino]-7-[3-(4-ethylpiperazin-1-yl)propoxy]-6-methoxyquinoline-3-carbonitrile | IC50 | 9.0 [1], 90.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_1a5c5c56e661514ddb741b403c9c5852.svg) | 4-Fluoro-2-[[2-[2-methoxy-4-(4-propan-2-ylpiperazin-1-yl)anilino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]benzamide | IC50 | 0.7 [1], 0.8 [2], 130.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_1e5533de10c9bd91d01ffaddac78419e.svg) | 2,3-Difluoro-6-[[2-[2-methoxy-4-(4-propan-2-ylpiperazin-1-yl)anilino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]benzamide | IC50 | 1.3 [1], 213.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_91b662370fdee68cc390b04f5702015a.svg) | 2,4-Difluoro-6-[[2-[2-methoxy-4-(4-propan-2-ylpiperazin-1-yl)anilino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]benzamide | IC50 | 0.8 [1], 90.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_3e474ad277e3aade261d02c459b20465.svg) | 3-(2-Benzyl-3H-benzimidazol-5-yl)-1-(4-morpholin-4-ylcyclohexyl)pyrazolo[3,4-d]pyrimidin-4-amine | IC50 | 64.0 [1], 94.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_767b146788cfbfcfe1a00e3d00c96e15.svg) | 1-(4-Morpholin-4-ylcyclohexyl)-3-[2-(thiophen-2-ylmethyl)-3H-benzimidazol-5-yl]pyrazolo[3,4-d]pyrimidin-4-amine | IC50 | 23.0 [1], 25.0 [2], 56.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_36b53dca38aae2b0af115c381829bb9e.svg) | 3-[2-[(2-Methoxyphenyl)methyl]-3H-benzimidazol-5-yl]-1-(4-morpholin-4-ylcyclohexyl)pyrazolo[3,4-d]pyrimidin-4-amine | IC50 | 81.0 [1], 142.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_cb5041df32b06860d62e6ca693f8b611.svg) | N-[5-[(3,5-Difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide | IC50 | 1441.0 [1], 2350.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_01bcc316216da75d9d4a312862920a58.svg) | N-[5-[(3,5-Difluorophenyl)methyl]-1H-indazol-3-yl]-2-(2-methoxyethylamino)-4-(4-methylpiperazin-1-yl)benzamide | IC50 | 1103.0 [1], 2112.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_763c4ada1395a0ebd1cbac5524528714.svg) | N-(2,6-Difluorophenyl)-3-[3-[2-[5-ethyl-2-methoxy-4-[4-(4-methylsulfonylpiperazin-1-yl)piperidin-1-yl]anilino]pyrimidin-4-yl]imidazo[1,2-a]pyridin-2-yl]benzamide | IC50 | 7.0 [1], 100.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_db996c87963c3eb915b3da91b3ab8301.svg) | 1-[4-[3-[4-Amino-5-[3-(7-oxabicyclo[2.2.1]heptan-1-ylmethoxy)phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclobutyl]piperazin-1-yl]ethanone | IC50 | 9.4 [1], 10.0 [2], 16.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_ec64e6990f290625583bcb6e1323aa45.svg) | 1-(2-Aminopyrid-4-yl-methyl)-5,5-dimethyl-3-(4-trifluoromethylsulfanylphenyl)imidazolidine-2,4-dione | IC50 | 34.0 [1], 92.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_202d584ecf038ac1c6e26d53e1125893.svg) | 1-[[2-(Ethylamino)pyridin-4-yl]methyl]-5,5-dimethyl-3-[4-(trifluoromethylsulfanyl)phenyl]imidazolidine-2,4-dione | IC50 | 47.0 [1], 154.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_b64f3e59a5d248af3edffde750432738.svg) | 5,5-Dimethyl-1-(pyridin-4-ylmethyl)-3-(4-(trifluoromethylthio)phenyl)imidazolidine-2,4-dione | IC50 | 117.0 [1], 264.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_2caf7d1c2db7506ed8c7a6fd144f42c3.svg) | 5,5-Dimethyl-1-[[2-(methylamino)pyridin-4-yl]methyl]-3-[4-(trifluoromethylsulfanyl)phenyl]imidazolidine-2,4-dione | IC50 | 43.0 [1], 202.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_adf7e3cf650ffd5c6af4b84957951a0c.svg) | 1-[4-[3-[4-Amino-5-[2-fluoro-5-[[(2R)-oxolan-2-yl]methoxy]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclobutyl]piperazin-1-yl]ethanone | IC50 | 47.0 [1], 64.0 [2], 159.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_9cae663711c772968f855a6963234005.svg) | [3-[4-Amino-5-[3-(7-oxabicyclo[2.2.1]heptan-1-ylmethoxy)phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclobutyl]methanol | IC50 | 11.0 [1], 33.0 [2], 128.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_d99fcb2dce49636492472e261065e608.svg) | [3-[4-Amino-5-[3-[(4-methyl-7-oxabicyclo[2.2.1]heptan-1-yl)methoxy]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclobutyl]methanol | IC50 | 29.0 [1], 47.0 [2], 183.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_78dd939207cb0503fa3cbab2732a9f06.svg) | 7-[3-(Azetidin-1-ylmethyl)cyclobutyl]-5-[3-(7-oxabicyclo[2.2.1]heptan-1-ylmethoxy)phenyl]pyrrolo[2,3-d]pyrimidin-4-amine | IC50 | 14.0 [1], 46.0 [2], 53.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_bbd19746be34973ec37699d0d51ea0fd.svg) | 5-[3-[[(2S)-Oxolan-2-yl]methoxy]phenyl]-7-[3-[(1-oxo-1,4-thiazinan-4-yl)methyl]cyclobutyl]pyrrolo[2,3-d]pyrimidin-4-amine | IC50 | 80.0 [1], 92.0 [2], 232.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_a7fde301c04af122ad328d1cb3f126ab.svg) | 1-[4-[3-[4-Amino-5-[2-fluoro-3-[[(2S)-oxolan-2-yl]methoxy]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclobutyl]piperazin-1-yl]ethanone | IC50 | 15.0 [1], 16.0 [2] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_42560635bf4e3c744e26ddd4cb7cca79.svg) | 5-[2-Fluoro-5-(7-oxabicyclo[2.2.1]heptan-1-ylmethoxy)phenyl]-7-[3-[(1-oxo-1,4-thiazinan-4-yl)methyl]cyclobutyl]pyrrolo[2,3-d]pyrimidin-4-amine | IC50 | 7.3 [1], 8.3 [2], 8.9 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_415e5406ca2a6010c8a610ccdf17da6b.svg) | 5-[2-Fluoro-5-[[(2S)-oxolan-2-yl]methoxy]phenyl]-7-[3-[(1-oxo-1,4-thiazinan-4-yl)methyl]cyclobutyl]pyrrolo[2,3-d]pyrimidin-4-amine | IC50 | 14.0 [1], 16.0 [2], 27.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_f5850025e2e3e60e0f9eb069e534a9d3.svg) | 1-[4-[3-[4-Amino-5-[2-fluoro-5-(7-oxabicyclo[2.2.1]heptan-1-ylmethoxy)phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclobutyl]piperazin-1-yl]ethanone | IC50 | 7.8 [1], 12.0 [2], 13.0 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_b4665db4d09c8a30d40ab4f1331ffab0.svg) | 1-[4-[3-[4-Amino-5-[2-fluoro-3-(7-oxabicyclo[2.2.1]heptan-1-ylmethoxy)phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclobutyl]piperazin-1-yl]ethanone | IC50 | 2.8 [1], 4.6 [2], 9.6 [3] |
![](https://images.aatbio.com/dataset/ic50/insulin-like-growth-factor-i-receptor_0e12651d8adf8b4a6f9c847d7faf8c78.svg) | 3-[8-Amino-1-(4-ethoxy-2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutan-1-ol | IC50 | 0.6 [1], 4.0 [2], 440.0 [3] |